Model for End-Stage Liver Disease and Sodium Velocity Predicts Overall Survival in Nonmetastatic Hepatocellular Carcinoma Patients

Table 1

Characteristics of the 182 subjects included in this study.

Characteristic	N=182
Age, mean (SD)	61.8 (11.1)
Gender, n (%)
Male	133 (73%)
Female	49 (27%)
Stage, n (%)
I	65 (36%)
II	51 (66%)
III	66 (36)
AFP (ng/mL)
< 400	127 (70%)
> 400	55 (30%)
Race, n (%)
White	107 (59%)
Black/African American	54 (30%)
Asian	5 (2%)
Other/Unknown	16 (9%)
Ethnicity, n (%)
Not Hispanic/Latino	85 (47%)
Hispanic/Latino	97 (54%)
Etiology of cirrhosis, n (%)
HCV	120 (66%)
HBV	13 (7%)
HBV + HCV	4 (2%)
Alcoholism	24 (13%)
Unknown	21 (12%)
MELD-Na, median (IQR)	9.7 (7.5 to 13.3)
MELD-Na_90, median (IQR)	11.8 (8.5 to 18.8)